Clinical factors associated with coagulation, such as aPTT, PT, and PLT, are also significantly different between control subjects and RPL patients, suggesting that thromboembolic diseases, such as thrombophilia, may be associated with RPL [31]. This evidence concerns the gene F2 and Rare hereditary thrombophilia.